Business Wire

NY-DILIGENT

27.5.2021 19:09:08 CEST | Business Wire | Press release

Share
Diligent’s Modern Leadership Initiative Adds New Partners to Advance Gender Equality in Leadership Positions in Europe

Diligent Corporation , the global leader in SaaS governance, risk and compliance, today announced the addition of four new partners, all based in Spain – Esade Center for Corporate Governance , Fundación Woman Forward , Instituto de Gobernanza Empresarial and WomenCEO – in its growing Modern Leadership initiative, which was created to further increase diverse representation in global businesses at the executive and board levels.

These organizations are committed to promoting best corporate governance practices, including increasing diversity and inclusion. According to research conducted by the Diligent Institute , men currently hold approximately three times more board leadership positions than women. The Modern Leadership initiative, which seeks to improve this statistic, helps companies measure and report on diversity as a part of their environmental, social and governance strategy.

“Esade’s Center for Corporate Governance is deeply passionate about the role women play in business success and growth,” said Mario Lara, Director of Esade Madrid and the Center for Corporate Governance. “Progress in achieving equality at the board and senior leadership levels is still nowhere near the rate it should be, which is why global initiatives like Diligent’s Modern Leadership are vital in changing the landscape and trajectory for women leaders.”

The new Spanish organizations joining the Modern Leadership initiative include:

  • Esade Center for Corporate Governance - The Center for Corporate Governance together with the Esade Alumni Club of Directors aims to become a leading reference center in the field of corporate governance in Spain. The Esade alumni network is the largest in Europe and one of the most expansive in the world, comprising over 60,000 members in 118 countries.
  • Fundación Woman Forward - The foundation is a non-profit institution that promotes women empowerment, gender equality, and diversity, using training and research. Woman Forward encourages and helps to strengthen the role of women in business.
  • Instituto de Gobernanza Empresarial - The Institute of Business Governance provides training and networking opportunities, and disseminates research to promote a business culture that is committed to corporate governance.
  • WomenCEO - WomenCEO aims to make women visible in the boardroom while demonstrating the need for them to be counted on in economic and social spheres. The organization believes that women are influential, both on the board of directors and in management positions in companies and institutions.

“Closing the gender gap in leadership is a global challenge that we have a greater chance to solve with international coordination,” said Brian Stafford, CEO of Diligent. “This is why expanding Diligent’s Modern Leadership initiative to include these organizations and others like them is imperative. Together, we can use our networks to identify, present and fill leadership positions for diverse candidates in the region and beyond.”

Diligent is committed to driving diversity by enacting change at the board level. To learn more about Diligent’s Modern Leadership initiative, please visit https://diligentmodernleadership.com .

About Diligent Corporation

Diligent is the largest governance, risk and compliance (GRC) SaaS provider, serving more than one million users from over 25,000 organizations around the globe. Our modern GRC platform ensures boards, executives and other leaders have a holistic, integrated view of audit, risk, information security, ethics and compliance across the organization.

Diligent brings technology, insights and confidence to leaders so they can build more effective, equitable and successful organizations. We empower 79% of the Fortune 500, 90% of the FTSE 100 and 83% of the ASX 200 to improve their bottom line, to keep pace with stakeholder expectations and to create a lasting, positive impact on the world.

For more information, visit www.diligent.com .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release

FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release

In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo

Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release

Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d

Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release

IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye